Featuring Michelle Tarver, M.D., Ph.D. from FDA, CDRH
Live! #81 presentation and panel | Recorded 8 August 2024

Available on demand.
RQM+ welcomes Michelle Tarver, M.D., Ph.D., Acting CDRH Director and Deputy Center Director for Transformation, FDA, CDRH, to a presentation and panel discussion aimed at increasing awareness and understanding of equity in the medical device and IVD space.
Objectives:
- Regulatory Expectations
Examining health equity concerns, regulatory efforts to promote equity, and FDA requirements for enhancing diversity in clinical trials - Healthcare at Home
Exploring the “Home as a Healthcare Hub” initiative and its implications for health equity, including the challenges and opportunities of integrating healthcare services at home - Industry Perspectives
Providing insights from industry leaders on how medical device companies are addressing health equity, with a focus on real-world examples and action plans - Action Plans and Strategies
Sharing best practices for developing and implementing plans that assess diversity, explore risks, and identify actions to address health equity within medical device companies - Interactive Q&A
Offering an opportunity for participants to engage with experts, ask questions, and gain a deeper understanding of the topic
Complete the form on this page to watch the recording and download the slides.
Panelists:
- Michelle Tarver, M.D., Ph.D. – Acting Director and Deputy Center Director for Transformation, FDA, CDRH
- Allison Komiyama, Ph.D., RAC – Vice President, MedTech Innovations, RQM+
- Jon Gimbel, Ph.D. – Vice President of Technical, RQM+
- Brandy Chittester – Senior Director, Clinical Operations, RQM+
- Jaishankar (Jai) Kutty, Ph.D. – Vice President, Global Regulatory Affairs, RQM+ (moderator)
Certificate of Participation available upon request for live attendees.
Get Your Copy Now
Fields marked with * are required.